NCT06960889 - A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions

Esophageal Cancer (EsC)

Interventions

OTHER

radiotherapy

Definitive radiotherapy or radiotherapy-based combined modality therapy

DRUG

Immunotherapy

Immune checkpoint inhibitors as monotherapy or in combination with other therapies

PROCEDURE

surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines

Radical esophagectomy with or without neoadjuvant/adjuvant therapy

Trial Locations (1)

510515

Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors

lead

Nanfang Hospital, Southern Medical University

OTHER